ACT European Summit launches Networking Forum
New Networking Forum to be introduced in 2007
Advanstar Communications, a leading publishing and event organisation, is to introduce an innovative networking forum to run alongside its Applied Clinical Trial European Summit from 29-31 October next year at the Dorint Sofitel Schweizerhof, Berlin, Germany. The forum will become a key part of the 2007 event, and will provide vendors with a valuable platform to meet and do business with purchasers and key influential figures from leading pharmaceutical, biotech and contract research organisations. The networking forum will enable hosts (vendors) to invite a number of their top clients and/or prospective clients to the event as hosted delegates. This will provide a unique environment in which all participants in ACT can network and do business.
"The Networking Forum has been launched in direct response to research conducted amongst suppliers to this market into what they need and want from their industry event. It will enable vendors to do business away from the traditional exhibition format in a relaxed but professional environment, enabling them to offer the very best customer service and hospitality to their existing clients and potential customers," commented event director Jessica Blue.
The ACT European Summit and Networking Forum is the leading information and networking event for senior level European clinical trials professionals. The 3 day event consists of a day of preconference seminars followed by 2 days of plenary sessions and workshops. The content focuses on the latest issues and trends affecting: clinical research, clinical trials, clinical operations, regulatory affairs, data management/EDC, project management, quality assurance and drug safety.
www.actsummit.com
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
